{"entity":{"type":"insider","cik":"0001719678","url":"/insider/0001719678","json_url":"/insider/0001719678.json","name":"Vogt Frederick G","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2022-06-02","last":"2025-05-16","span_basis":"filed_date"},"name_variants":[{"name":"Vogt Frederick G","source":"filing","n_filings":3,"first_seen":"2022-06-02","last_seen":"2025-05-16"}],"transactions":[{"id":4469319,"accession":"0001104659-25-049999","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-049999","line_url":"/filing/0001104659-25-049999#line-1","is_derivative":false,"issuer_cik":"0001425205","issuer_name":"IOVANCE BIOTHERAPEUTICS, INC.","issuer_ticker":"IOVA","issuer_name_source":null,"issuer_url":"/issuer/0001425205","owner_cik":"0001719678","owner_name":"Vogt Frederick G","owner_display_name":"Vogt Frederick G","owner_url":"/insider/0001719678","role":"Director, Officer (Interim CEO & General Counsel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Interim CEO & General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.69,"price_display":"1.69","price_state":"stated","total_value":42250.0,"total_display":"42,250.00","total_whole":"42,250","shares_owned_after":374646.0,"shares_owned_after_display":"374,646","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-14","filed_date":"2025-05-16","scope":"insider"},{"id":6418987,"accession":"0001104659-22-122556","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-122556","line_url":"/filing/0001104659-22-122556#line-1","is_derivative":false,"issuer_cik":"0001425205","issuer_name":"IOVANCE BIOTHERAPEUTICS, INC.","issuer_ticker":"IOVA","issuer_name_source":null,"issuer_url":"/issuer/0001425205","owner_cik":"0001719678","owner_name":"Vogt Frederick G","owner_display_name":"Vogt Frederick G","owner_url":"/insider/0001719678","role":"Officer (Interim CEO & General Counsel)","role_mark":"O","role_mark_label":"Officer (Interim CEO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Interim CEO & General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":5.98,"price_display":"5.98","price_state":"stated","total_value":5980.0,"total_display":"5,980.00","total_whole":"5,980","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-28","filed_date":"2022-11-28","scope":"insider"},{"id":6636494,"accession":"0001104659-22-067758","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-067758","line_url":"/filing/0001104659-22-067758#line-1","is_derivative":false,"issuer_cik":"0001425205","issuer_name":"IOVANCE BIOTHERAPEUTICS, INC.","issuer_ticker":"IOVA","issuer_name_source":null,"issuer_url":"/issuer/0001425205","owner_cik":"0001719678","owner_name":"Vogt Frederick G","owner_display_name":"Vogt Frederick G","owner_url":"/insider/0001719678","role":"Officer (Interim CEO & General Counsel)","role_mark":"O","role_mark_label":"Officer (Interim CEO & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Interim CEO & General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":6.44,"price_display":"6.44","price_state":"stated","total_value":6440.0,"total_display":"6,440.00","total_whole":"6,440","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-01","filed_date":"2022-06-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001425205","name":"IOVANCE BIOTHERAPEUTICS, INC.","url":"/issuer/0001425205","role":"Director, Officer (Interim CEO & General Counsel)","n_filings":3,"first_seen":"2022-06-02","last_seen":"2025-05-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001719678","retrieved_at":"2026-08-23T06:42:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}